Login

Weight loss drugmaker Zealand Pharma selects Boston to anchor US growth

Danish biotech firm's lease bolsters recovering life sciences real estate market
Zealand Pharma leased the fourth floor at 35 Cambridgepark Drive in Cambridge, Massachusetts. (CoStar)
Zealand Pharma leased the fourth floor at 35 Cambridgepark Drive in Cambridge, Massachusetts. (CoStar)
CoStar News
March 20, 2026 | 8:45 P.M.

A global life sciences giant signed a lease in Boston to anchor its U.S. operations as it builds its presence in the nation's increasingly competitive obesity drug market.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE